236 related articles for article (PubMed ID: 33912166)
1. Illumination of Molecular Pathways in Multiple Sclerosis Lesions and the Immune Mechanism of Matrine Treatment in EAE, a Mouse Model of MS.
Dou M; Zhou X; Li L; Zhang M; Wang W; Wang M; Jing Y; Ma R; Zhao J; Zhu L
Front Immunol; 2021; 12():640778. PubMed ID: 33912166
[TBL] [Abstract][Full Text] [Related]
2. Matrine promotes oligodendrocyte development in CNS autoimmunity through the PI3K/Akt signaling pathway.
Liu SQ; Zhang ML; Zhang HJ; Liu FZ; Chu RJ; Zhang GX; Zhu L
Life Sci; 2017 Jul; 180():36-41. PubMed ID: 28499934
[TBL] [Abstract][Full Text] [Related]
3. Matrine downregulates IL-33/ST2 expression in the central nervous system of rats with experimental autoimmune encephalomyelitis.
Zhao X; Zhang X; Lv Y; Xu Y; Li M; Pan Q; Chu Y; Liu N; Zhang GX; Zhu L
Immunol Lett; 2016 Oct; 178():97-104. PubMed ID: 27562326
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis.
Chu Y; Jing Y; Zhao X; Wang M; Zhang M; Ma R; Ma W; Lv Y; Zhu L
J Neuroimmunol; 2021 Mar; 352():577480. PubMed ID: 33493985
[TBL] [Abstract][Full Text] [Related]
5. Matrine Inhibits CNS Autoimmunity Through an IFN-β-Dependent Mechanism.
Chu YJ; Ma WD; Thome R; Ping JD; Liu FZ; Wang MR; Zhang ML; Zhang G; Zhu L
Front Immunol; 2020; 11():569530. PubMed ID: 33101289
[TBL] [Abstract][Full Text] [Related]
6. Matrine promotes NT3 expression in CNS cells in experimental autoimmune encephalomyelitis.
Zhang ML; Zhang XJ; Kang J; Zhang HJ; Chen XL; Liu N; Liu SQ; Ma WD; Zhang GX; Zhu L
Neurosci Lett; 2017 May; 649():100-106. PubMed ID: 28392360
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of immunomodulatory molecules by matrine treatment in experimental autoimmune encephalomyelitis.
Liu N; Kan QC; Zhang XJ; Xv YM; Zhang S; Zhang GX; Zhu L
Exp Mol Pathol; 2014 Dec; 97(3):470-6. PubMed ID: 25303900
[TBL] [Abstract][Full Text] [Related]
8. Matrine injection inhibits pancreatic cancer growth via modulating carbonic anhydrases- a network pharmacology-based study with in vitro validation.
Xu PL; Cheng CS; Jiao JY; Chen H; Chen Z; Li P
J Ethnopharmacol; 2022 Apr; 287():114691. PubMed ID: 34597654
[TBL] [Abstract][Full Text] [Related]
9. Matrine regulates glutamate-related excitotoxic factors in experimental autoimmune encephalomyelitis.
Kan QC; Zhang S; Xu YM; Zhang GX; Zhu L
Neurosci Lett; 2014 Feb; 560():92-7. PubMed ID: 24368216
[TBL] [Abstract][Full Text] [Related]
10. Identification of the Mechanism of Matrine Combined with Glycyrrhizin for Hepatocellular Carcinoma Treatment through Network Pharmacology and Bioinformatics Analysis.
Han T; Liu Y; Chen Y; Chen T; Li Y; Li Q; Zhao M
Oxid Med Cell Longev; 2022; 2022():2663758. PubMed ID: 36193082
[TBL] [Abstract][Full Text] [Related]
11. Matrine protects neuro-axon from CNS inflammation-induced injury.
Kan QC; Lv P; Zhang XJ; Xu YM; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Feb; 98(1):124-30. PubMed ID: 25576296
[TBL] [Abstract][Full Text] [Related]
12. Matrine treatment induced an A2 astrocyte phenotype and protected the blood-brain barrier in CNS autoimmunity.
Jing Y; Ma R; Chu Y; Dou M; Wang M; Li X; Zhu L
J Chem Neuroanat; 2021 Nov; 117():102004. PubMed ID: 34280490
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of matrine on experimental autoimmune encephalomyelitis via regulation of ProNGF and NGF signaling.
Zhu L; Pan QX; Zhang XJ; Xu YM; Chu YJ; Liu N; Lv P; Zhang GX; Kan QC
Exp Mol Pathol; 2016 Apr; 100(2):337-43. PubMed ID: 26681653
[TBL] [Abstract][Full Text] [Related]
14. Systematic elucidation of the bioactive alkaloids and potential mechanism from Sophora flavescens for the treatment of eczema via network pharmacology.
Lin Y; Chen XJ; He L; Yan XL; Li QR; Zhang X; He MH; Chang S; Tu B; Long QD; Zeng Z
J Ethnopharmacol; 2023 Jan; 301():115799. PubMed ID: 36216196
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of matrine on blood-brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis.
Zhang S; Kan QC; Xu Y; Zhang GX; Zhu L
Mediators Inflamm; 2013; 2013():736085. PubMed ID: 24194630
[TBL] [Abstract][Full Text] [Related]
16. Matrine protects oligodendrocytes by inhibiting their apoptosis and enhancing mitochondrial autophagy.
Wang MR; Zhang XJ; Liu HC; Ma WD; Zhang ML; Zhang Y; Li X; Dou MM; Jing YL; Chu YJ; Zhu L
Brain Res Bull; 2019 Nov; 153():30-38. PubMed ID: 31404585
[TBL] [Abstract][Full Text] [Related]
17. Matrine inhibits the Wnt3a/β-catenin/TCF7L2 signaling pathway in experimental autoimmune encephalomyelitis.
Ma R; Chu Y; Dou M; Jing Y; Zhao X; Li X; Li S; Zhang Y; Wang L; Zhu L
J Neuroimmunol; 2022 Jun; 367():577876. PubMed ID: 35489221
[TBL] [Abstract][Full Text] [Related]
18. Regulatory effects of antitumor agent matrine on FOXO and PI3K-AKT pathway in castration-resistant prostate cancer cells.
Li Q; Huang H; He Z; Sun Y; Tang Y; Shang X; Wang C
Sci China Life Sci; 2018 May; 61(5):550-558. PubMed ID: 29119376
[TBL] [Abstract][Full Text] [Related]
19. Matrine suppresses expression of adhesion molecules and chemokines as a mechanism underlying its therapeutic effect in CNS autoimmunity.
Kan QC; Zhu L; Liu N; Zhang GX
Immunol Res; 2013 May; 56(1):189-96. PubMed ID: 23549837
[TBL] [Abstract][Full Text] [Related]
20. Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Kan QC; Pan QX; Zhang XJ; Chu YJ; Liu N; Lv P; Zhang GX; Zhu L
Exp Mol Pathol; 2015 Oct; 99(2):212-9. PubMed ID: 26093163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
